Ruth Fein

3 weeks ago | healthtree.org | Ruth Fein

It was January 2024, and Paola had recently finished medical school. She was just settling into her new job at a San Diego company dedicated to advancing multiple myeloma research. Then the call came from her parents. “Dad was feeling really bad,” she remembers. “He had a pain in his chest, and I told them to go to the ER, thinking that it was probably a heart attack.” In fact, it was a lesion in his rib. A biopsy at the El Paso, Texas, hospital near where they lived revealed it was multiple myeloma.

Jan 23, 2025 | patientpower.info | Ruth Fein

Getty Images/TzidoNon-Hodgkin lymphomas (NHL) represent a wide range of lymphomas. Diffuse large B-cell lymphoma and follicular lymphoma are two of the most common subtypes, and mantle cell lymphoma (MCL) is a particularly aggressive subtype. As scientific advances in diagnosis and treatment lead to more and better treatment options, the prognosis for people with NHLcontinues to improve.

Jan 23, 2025 | patientpower.info | Ruth Fein

Getty Images/sanjeriEssential thrombocythemia (ET) and polycythemia vera (PV) are very different diseases, but they are both myeloproliferative neoplasms (MPNs). In this post- 2024 American Society of Hematology (ASH) Annual Meeting & Exposition interview, Patient Power spoke with MPN specialist Gabriela Hobbs, MD, associate professor of medicine at Harvard Medical School and clinical director of leukemia service at Massachusetts General.

Jan 7, 2025 | patientpower.info | Ruth Fein

While acute lymphocytic leukemia (ALL) is most common in children and young adults, it can occur in older adults as well. It begins in the bone marrow where blood cells are made and quickly affects a type of white blood cell called lymphocytes. It typically progresses very quickly.

Dec 18, 2024 | patientpower.info | Ruth Fein

Getty Images/fotostormMultiple myeloma (MM) was spotlighted in multiple sessions at the 2024 American Society of Hematology (ASH) Annual Meeting & Exposition. One hot topic was improving prognostication – the ability to predict disease progression in a person living with MM.